Gene · 8438
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCPH1 and DNA Damage Response Pathway Genes as Candidate Susceptibility Loci in Hereditary Breast Cancer. | Diagnostics (Basel) | 2026 | 42793752 | PubTator, text mining | PubMed |
| Whole-genome sequencing identifies a potentially causative homozygous splicing variant in RAD54 like in non-obstructive azoospermia. | Int J Reprod Biomed | 2026 | 42774555 | PubTator, text mining | PubMed |
| The dynamics of RAD51 foci formation and elongation in living human cells. | Nucleic Acids Res | 2026 | 42725434 | PubTator, text mining | PubMed |
| RAD54L coordinates the nucleolar DNA damage response to maintain rDNA stability. | EMBO J | 2026 | 42493648 | PubTator, text mining | PubMed |
| Role of chromatin remodeling and immunopharmacology in cancer therapy. | Mol Med | 2026 | 42458295 | PubTator, text mining | PubMed |
| Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States. | Urol Oncol | 2026 | 42431822 | PubTator, text mining | PubMed |
| NSUN2-mediated m5C modification of E2F1 promotes lung adenocarcinoma progression via the RAD54L signaling axis. | Respir Res | 2026 | 42399962 | PubTator, text mining | PubMed |
| FBH1 and RAD54L directly interact and cooperate to drive replication fork reversal. | bioRxiv | 2026 | 42239417 | PubTator, text mining | PubMed |
| Ethnicity-specific molecular subtypes and a machine-learning risk model in Asian patients with non-muscle-invasive bladder cancer. | Sci Rep | 2026 | 42215586 | PubTator, text mining | PubMed |
| RAD54L promotes nascent DNA degradation and radial chromosome formation in FANC-deficient cells. | bioRxiv | 2026 | 42182380 | PubTator, text mining | PubMed |
| Replication fork remodeling proteins, Smc5/6 and Rtt107, promote palindrome-mediated genome instability. | bioRxiv | 2026 | 42094383 | PubTator, text mining | PubMed |
| Potential Rad54 separation of function mutation highlights unique roles during homologous recombination. | PLoS Genet | 2026 | 42044161 | PubTator, text mining | PubMed |
| The eukaryotic homology search complex distorts donor DNA structure to probe for homology. | Genes Dev | 2026 | 41942263 | PubTator, text mining | PubMed |
| Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition. | PLoS One | 2026 | 41931484 | PubTator, text mining | PubMed |
| Structures and molecular mechanisms of RAD54B in modulating homologous recombination. | bioRxiv | 2026 | 41929041 | PubTator, text mining | PubMed |
| Identification of circRNA/lncRNA-miRNA-Transcription Factor-mRNA Networks to Identify Potential Biomarkers in Response to Neoadjuvant Therapy for Breast Cancer. | Breast Cancer (Dove Med Press) | 2026 | 41926491 | PubTator, text mining | PubMed |
| B-type lamins maintain transcriptional homeostasis by spatially controlling chromatin-speckle proximity. | Nucleic Acids Res | 2026 | 41909953 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify the EXO1-CAF-1 pathway suppressing R-loop-associated DNA damage. | Nucleic Acids Res | 2026 | 41841497 | PubTator, text mining | PubMed |
| The dual role of BRD9 in cancer: Mechanistic insights and therapeutic prospects. | iScience | 2026 | 41797932 | PubTator, text mining | PubMed |
| [Rosai-Dorfman disease of the breast: a clinicopathological and molecular genetic analysis of four cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41795986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8438/papers